Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Mutant mice help researchers understand hair growth and related genetic factors.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Nanoparticle systems make cancer treatment less toxic.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The HR protein's role as a repressor is essential for controlling hair growth.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Doctors need to be better prepared to assess and treat obesity in patients.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

All three treatments reduce hirsutism, but spironolactone works best long-term.